169 related articles for article (PubMed ID: 29669440)
1. Thrombin Generation Assay Detects Moderate-Intensity Statin-Induced Reduction of Hypercoagulability in Diabetes.
Park HS; Gu JY; Yoo HJ; Han SE; Park CH; Kim YI; Nam-Goong IS; Kim ES; Kim HK
Clin Appl Thromb Hemost; 2018 Oct; 24(7):1095-1101. PubMed ID: 29669440
[TBL] [Abstract][Full Text] [Related]
2. Coagulation proteins influencing global coagulation assays in cirrhosis: hypercoagulability in cirrhosis assessed by thrombomodulin-induced thrombin generation assay.
Youngwon N; Kim JE; Lim HS; Han KS; Kim HK
Biomed Res Int; 2013; 2013():856754. PubMed ID: 23555099
[TBL] [Abstract][Full Text] [Related]
3. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
Choi Q; Kim JE; Hyun J; Han KS; Kim HK
Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
[TBL] [Abstract][Full Text] [Related]
4. Influence of blood lipids on global coagulation test results.
Kim JA; Kim JE; Song SH; Kim HK
Ann Lab Med; 2015 Jan; 35(1):15-21. PubMed ID: 25553275
[TBL] [Abstract][Full Text] [Related]
5. Global coagulation tests: their applicability for measuring direct factor Xa- and thrombin inhibition and reversal of anticoagulation by prothrombin complex concentrate.
Dinkelaar J; Patiwael S; Harenberg J; Leyte A; Brinkman HJ
Clin Chem Lab Med; 2014 Nov; 52(11):1615-23. PubMed ID: 24902009
[TBL] [Abstract][Full Text] [Related]
6. Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial.
Orsi FA; Biedermann JS; Kruip MJHA; van der Meer FJ; Rosendaal FR; van Hylckama Vlieg A; Bos MHA; Leebeek FWG; Cannegieter SC; Lijfering WM
J Thromb Haemost; 2019 Feb; 17(2):319-328. PubMed ID: 30565854
[TBL] [Abstract][Full Text] [Related]
7. Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors.
Tripodi A; Ammollo CT; Semeraro F; Colucci M; Malchiodi E; Verrua E; Ferrante E; Arnaldi G; Trementino L; Padovan L; Chantarangkul V; Peyvandi F; Mantovani G
Endocrine; 2017 May; 56(2):298-307. PubMed ID: 27448294
[TBL] [Abstract][Full Text] [Related]
8. Influence of coagulation and anticoagulant factors on global coagulation assays in healthy adults.
Kim SY; Kim JE; Kim HK; Kim I; Yoon SS; Park S
Am J Clin Pathol; 2013 Mar; 139(3):370-9. PubMed ID: 23429374
[TBL] [Abstract][Full Text] [Related]
9. High coagulation factor levels and low protein C levels contribute to enhanced thrombin generation in patients with diabetes who do not have macrovascular complications.
Kim HK; Kim JE; Park SH; Kim YI; Nam-Goong IS; Kim ES
J Diabetes Complications; 2014; 28(3):365-9. PubMed ID: 24560421
[TBL] [Abstract][Full Text] [Related]
10. Prominent protein Z-induced thrombin inhibition in cirrhosis: a new functional assay for hypercoagulability assessment.
Kim SY; Kim JE; Kim YJ; Han KS; Kim HK
J Gastroenterol Hepatol; 2015 Apr; 30(4):784-93. PubMed ID: 25303721
[TBL] [Abstract][Full Text] [Related]
11. Statins and blood coagulation.
Undas A; Brummel-Ziedins KE; Mann KG
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):287-94. PubMed ID: 15569822
[TBL] [Abstract][Full Text] [Related]
12. Influence of ABO type on global coagulation assay results: effect of coagulation factor VIII.
Choi Q; Kim JE; Kim SY; Han KS; Kim HK
Clin Chem Lab Med; 2015 Aug; 53(9):1425-32. PubMed ID: 25503670
[TBL] [Abstract][Full Text] [Related]
13. Enhanced thrombin generation in women with a history of oral contraception-related venous thrombosis.
Anžej Doma S; Vučnik M; Božič Mijovski M; Peternel P; Stegnar M
Thromb Res; 2013 Nov; 132(5):621-6. PubMed ID: 24083963
[TBL] [Abstract][Full Text] [Related]
14. Cancer cell-induced neutrophil extracellular traps promote both hypercoagulability and cancer progression.
Jung HS; Gu J; Kim JE; Nam Y; Song JW; Kim HK
PLoS One; 2019; 14(4):e0216055. PubMed ID: 31034495
[TBL] [Abstract][Full Text] [Related]
15. Hypercoagulability following major partial liver resection - detected by thrombomodulin-modified thrombin generation testing.
Potze W; Alkozai EM; Adelmeijer J; Porte RJ; Lisman T
Aliment Pharmacol Ther; 2015 Jan; 41(2):189-98. PubMed ID: 25382796
[TBL] [Abstract][Full Text] [Related]
16. Contact system activation and high thrombin generation in hyperthyroidism.
Kim N; Gu JY; Yoo HJ; Han SE; Kim YI; Nam-Goong IS; Kim ES; Kim HK
Eur J Endocrinol; 2017 May; 176(5):583-589. PubMed ID: 28137735
[TBL] [Abstract][Full Text] [Related]
17. Statins decrease thrombin generation in patients with hypercholesterolemia.
Tripodi A; Pellegatta F; Chantarangkul V; Grigore L; Garlaschelli K; Baragetti A; Lemma L; Catapano A
Eur J Intern Med; 2014 Jun; 25(5):449-51. PubMed ID: 24784951
[TBL] [Abstract][Full Text] [Related]
18. Thrombin Generation Assay and Hemostatic Profile for Elucidating Hypercoagulability in Endogenous Canine Hyperadrenocorticism.
Vargas-Mora SE; Romão FG; Dos Santos B; Carvalho MDG; Duarte RCF; De Marco Bernardes V; Lopes PA; Takahira RK
Top Companion Anim Med; 2021 Nov; 45():100581. PubMed ID: 34509666
[TBL] [Abstract][Full Text] [Related]
19. Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.
Krysiak R; Okopień B; Herman Z
Drugs; 2003; 63(17):1821-54. PubMed ID: 12921488
[TBL] [Abstract][Full Text] [Related]
20. Thrombin generation and coagulation factor activities: evaluation and comparison with the international normalized ratio.
Christensen TD; Jensen C; Larsen TB; Christiansen K; Sørensen B
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):358-65. PubMed ID: 19417631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
